White House Publishes Federal Implementation Plan for National HIV/AIDS Strategy
August 26, 2022 — The National HIV/AIDS Strategy (NHAS) Federal Implementation Plan reflects the collaborative work of representatives from 10 federal departments and details more than 380 action items they will implement individually and collaboratively. This plan documents federal agencies’ commitments to programs, policies, research, and other activities needed to meet the NHAS goals. These critical activities, which encompass work to for fiscal years 2022–2025, will move our indicators of progress in the right directions.
New Insights into HIV Latent Cells Yield Potential Cure Targets
July 27, 2022 — In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.
Finding HIV’s ‘Sweet Spot’
July 22, 2022 — An NIH-funded team has found that patterns of sugars at the surface of our own human immune cells affect their vulnerability to HIV infection.
Creating a one-stop shop for HIV research
June 9, 2022 — access issue of the Journal of Acquired Immunodeficiency Syndrome (JAIDS) will highlight HIV implementation science findings, reported by scientists and implementations teams funded by the National Institutes of Health through the Ending the HIV Epidemic initiative. (JAIDS)
NIH Awards More than $20 Million to International HIV Database Centers
July 22, 2021 — The National Institutes of Health has renewed grants to seven regional centers that compose the International epidemiology Databases to Evaluate AIDS (IeDEA), awarding $20.8 million in first-year funding. The 15-year-old IeDEA program efficiently advances knowledge about HIV by pooling and analyzing de-identified health data from more than two million people with HIV on five continents to answer research questions that individual studies cannot address. The grants are expected to last five years and to total an estimated $100 million.
HIV Related Stigma Research as a Priority at the National Institutes of Health
April 22, 2021 — The National Institute of Health (NIH) recognizes that ending the HIV epidemic will require eliminating HIV-related stigma, which continues to be a critical barrier to the uptake of evidence-based HIV interventions, and in this article the authors provide an overview of NIH HIV stigma research and findings. (AIDS and Behavior)
HIV/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics
April 7, 2021 — Effective responses to concurrent COVID-19 and HIV/AIDS pandemics require a novel coordinated and collaborative global effort to accelerate biomedical research and implementation science to operationalize evidence-based interventions expeditiously. (The Journal of Infectious Diseases)
Scaling Up Covid-19 Vaccination in Africa – Lessons from the HIV Pandemic
March 31, 2021 — Concerns about access to Covid-19 vaccines in Africa resemble concerns raised about responding to the HIV pandemic in the mid-1990s and early 2000s, when highly active antiretroviral treatment was accessible in high-income countries but limited in African countries. (The New England Journal of Medicine)
Final HIV Prevention & Treatment Research Highlights from CROI 2021 (video)
March 12, 2021— Dr. Carl Dieffenbach, director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases, and his colleague Dr. Hillary Hoffman, joined HIV.gov for a conversation about the latest HIV prevention and treatment research presented during the 2021 Conference on Retroviruses and Opportunistic Infections. (HIV.gov)